(31) The time at which someone starts a treatment for obesity can itself be correlated with mental health difficulties, and the effects of the medication on weight, whether this is a dramatic reduction in weight, or a disappointing lack of weight reduction, can also trigger changes in mental health. (32) Based on major long-term trials, including FLOW (chronic kidney disease), SELECT (obesity/cardiovascular disease without diabetes), and SUSTAIN-6 (type 2 diabetes), semaglutide has demonstrated significant benefits across the cardiovascular and renal systems
Factors include your weight, age, kidney and liver function, other medications you take, and your overall health condition
Biochim Biophys Acta Rev Cancer
Louwagie, MD, PhD, of the Department of Internal Medicine at LewisGale Hospital Montgomery in Blacksburg, Va
Drugs like retatrutide, CagriSema, survodutide, and orforglipron are designed to build on what Ozempic started